Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Yehia Hashad"'
Autor:
Derek Y Kunimoto, Andrew J. Lotery, Yehia Hashad, Rahul N. Khurana, Charles C. Wykoff, Young Hee Yoon, Francesco Bandello, Werner Schmidt, Cedar, Eric H Souied, Grace Le, Jenny Jiao, David R. Chow, Andrew Chang, Xiao-yan Li, Sequoia Study Groups, Hansjürgen Agostini, Masahito Ohji, Rubens Belfort, Raj K. Maturi
Publikováno v:
Ophthalmology. 127:1331-1344
Purpose To compare the efficacy and safety of abicipar every 8 weeks and quarterly (after initial doses) versus ranibizumab every 4 weeks in treatment-naive patients with neovascular age-related macular degeneration (AMD). Design Two randomized, mult
Autor:
Hansjürgen Agostini, Young Hee Yoon, Cedar, Rahul N. Khurana, Charles C. Wykoff, David R. Chow, Raj K. Maturi, Andrew Chang, Derek Y Kunimoto, Rubens Belfort, Eric H Souied, Masahito Ohji, Francesco Bandello, Andrew J. Lotery, Kimmie Kim, Yehia Hashad, Xiao-yan Li, Jenny Jiao, Grace Le, Werner Schmidt, Sequoia Study Groups
Publikováno v:
Ophthalmology. 128(7)
To report the 2-year efficacy and safety of abicipar every 8 weeks and quarterly (after initial doses) compared with monthly ranibizumab in patients with treatment-naïve neovascular age-related macular degeneration (nAMD).Two multicenter, randomized
Autor:
Derek, Kunimoto, Young Hee, Yoon, Charles C, Wykoff, Andrew, Chang, Rahul N, Khurana, Raj K, Maturi, Hansjürgen, Agostini, Eric, Souied, David R, Chow, Andrew J, Lotery, Masahito, Ohji, Francesco, Bandello, Rubens, Belfort, Xiao-Yan, Li, Jenny, Jiao, Grace, Le, Werner, Schmidt, Yehia, Hashad
Publikováno v:
Ophthalmology. 127(10)
To compare the efficacy and safety of abicipar every 8 weeks and quarterly (after initial doses) versus ranibizumab every 4 weeks in treatment-naïve patients with neovascular age-related macular degeneration (AMD).Two randomized, multicenter, double
Autor:
Raj K. Maturi, Ayala Pollack, Harvey S. Uy, Monica Varano, Andre M. V. Gomes, Xiao-Yan Li, Harry Cui, Jean Lou, Yehia Hashad, Scott M. Whitcup
Publikováno v:
Retina. 37:e37-e40
Autor:
Yehia Hashad, Scott M. Whitcup, Pascale Massin, Anat Loewenstein, Jenny Jiao, Borja Corcóstegui, Sunil S. Patel, Xiao-yan Li, David Callanan
Publikováno v:
Graefe's Archive for Clinical and Experimental Ophthalmology. 255:463-473
To evaluate whether treatment with dexamethasone intravitreal implant (DEX implant) 0.7 mg every 5 months provides a similar average change in best-corrected visual acuity (BCVA) from baseline as ranibizumab 0.5 mg administered as per its European Su
Autor:
Uwe Pleyer, Jenny Jiao, Nuria María Gajate Paniagua, Corrine Dot, Ahmed Kamal, Adnan Tufail, Xiao-yan Li, Yehia Hashad, Susan Lightman, Jean Lou
Publikováno v:
Clinical Ophthalmology (Auckland, N.Z.)
Adnan Tufail,1 Sue Lightman,1 Ahmed Kamal,2 Uwe Pleyer,3 Nuria María Gajate Paniagua,4 Corrine Dot,5,6 Xiao-Yan Li,7 Jenny Jiao,7 Jean Lou,7 Yehia Hashad7For the CONSTANCE Study Group1Moorfields Eye Hospital, London, UK; 2Aintree University Hospital
Autor:
David S. Boyer, 1 Young Hee Yoon, MD, PhD, 2 Rubens Belfort, Jr, MD, PhD, 3 Francesco Bandello, 4 Raj K. Maturi, 5 Albert J. Augustin, 6 Xiao Yan Li, 7 Harry Cui, 7 Yehia Hashad, 7 Scott M. Whitcup, MDThe MEAD Study Group Principal Investigators: Suel Abujamra, James Acton, Fareed Ali, Andrew Antoszyk, Albert J. Augustin, Carl C. Awh, Adiel Barak, Karl Ulrich Bartz Schmidt, Caroline R. Baumal, Rubens Belfort, J.r., Muna Bhende, William Z. Bridges, David M. Brown, Trevor Carmichael, Ken Carnevale, Antonio M. Casella, Tom Chang, Daniel Chechik, San Ni Chen, Lawrence P. Chong, Victor Chong, Joel Corwin, Catherine Creuzot Garcher, Alan Cruess, Mark Daniell, Marcos P. de Avila, Haroldo Vieira de Moraes, Robert G. Devenyi, Bernard H. Doft, Mark Donaldson, Richard Dreyer, Dean Eliott, Harry M. Engel, Jan Ernest, Thomas F. Essman, Philip M. Falcone, Sharon Fekrat, Joseph R. Ferencz, Joao L. Ferreira, Joao Figueira, Ivan Fiser, Bradley Foster, Gregory M. Fox, William R. Freeman, S. P. Garg, Mark Gillies, David Glaser, Burton G. Goldstein, Andre M. V. Gomes, John R. Gonder, Lingam Gopal, Petrus Gous, Amod Gupta, Anurag Gupta, Lawrence Halperin, Dennis Han, Seenu M. Hariprasad, Frank G. Holz, Peter Kaiser, Bohdana Kalvodova, Barrett Katz, Randy S. Katz, Dariusz Kecik, Judianne Kellaway, Itamar Klemperer, Baruch Kuppermann, Paolo Lanzetta, Rosangela Lattanzio, Won Ki Lee, John Lehr, Monique Leys, Isaac Loose, Andrew Lotery, Da Wen Lu, Paul McCartney, Ajit B. Majji, Jose A. Martinez, Pascale Massin, Raj K. Maturi, Ugo Menchini, Geeta Menon, Mark Michels, Edoardo Midena, James Miller, Paul Mitchell, Joseph Moisseiev, Lawrence Morse, Rafael Navarro, Janos Nemeth, Henry Newland, Richard Newsom, John Nichols, Juan Orellana, Nicola Orzalesi, Augusto Paranhos, Robert Park, Susanna Park, Maurizio Battaglia Parodi, Peter R. Pavan, James Peace, Don J. Perez Ortiz, Ayala Pollack, Kim Ramaswamy, Ramakrishna Ratnakaram, Giuseppe Ravalico, Jiri Rehak, Kourous Rezaei, Stanislao Rizzo, Francisco J. Rodriguez Alvira, Jean Paul Romanet, Steven Rose, Richard B. Rosen, Luca Rossetti, Jose Maria Ruiz Moreno, SriniVas Sadda, Kenneth Sall, Dirk Sandner, Alvaro Fernandez Vega Sanz, Gil Sartani, Stefanie Schmickler, Steven D. Schwartz, Y. R. Sharma, Shwu Jiuan Sheu, Michael Singer, Sobha Sivaprasad, Gisele Soubrane, Petr Soucek, Eric H. Souied, Giovanni Staurenghi, Jan Studnicka, Marta Suarez Figueroa, Walter Y. Takahashi, Patrick L. Tsai, Lawrence J. Ulanski, Harvey Uy, Monica Varano, Miroslav Veith, Igor Vicha, Francesco Viola, Linda Visser, Dov Weinberger, Glenn L. Wing, Edmund Wong, Tien Wong, Edward Wylegala, Jiong Yan, Young Hee Yoon, Lucy H. Young, Hyeong G. Yu, Ingrid E. Zimmer Galler, TOGNETTO, DANIELE
Publikováno v:
Ozurdex MEAD Study Group & Newsom, R B 2014, ' Three-year, randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with diabetic macular edema ', Ophthalmology, vol. 121, no. 10, pp. 1904-1914 . https://doi.org/10.1016/j.ophtha.2014.04.024
Purpose: To evaluate the safety and efficacy of dexamethasone intravitreal implant (Ozurdex, DEX implant) 0.7 and 0.35 mg in the treatment of patients with diabetic macular edema (DME).Design: Two randomized, multicenter, masked, sham-controlled, pha
Autor:
Monica Varano, Scott M. Whitcup, Xiao-yan Li, Yehia Hashad, Harvey S. Uy, André Marcelo Vieira Gomes, Harry Cui, Ayala Pollack, Jean Lou, Raj K. Maturi
Publikováno v:
Retina. 36:1143-1152
Purpose:To evaluate the occurrence, management, and clinical significance of increases in intraocular pressure (IOP) in patients with diabetic macular edema treated with dexamethasone intravitreal implant (DEX implant).Methods:Randomized, multicenter
Publikováno v:
The British Journal of Ophthalmology
Background/aim To assess long-term effects of dexamethasone intravitreal implant (DEX implant) monotherapy on retinal morphology in diabetic macular oedema (DME). Methods Two multicentre, masked, phase III studies with identical protocols randomised
Autor:
Xiaoling Liang, Yehia Hashad, Ningli Wang, Xiao-yan Li, Jenny Jiao, Jean Lou, Xiaoxin Li, Gezhi Xu
Publikováno v:
Graefe's Archive for Clinical and Experimental Ophthalmology
Purpose The purpose of this study was to evaluate the safety and efficacy of dexamethasone intravitreal implant 0.7 mg (DEX) for treatment of macular edema associated with retinal vein occlusion (RVO). Methods This study was a six-month, randomized,